Judge Agrees POM Shouldn't Pretend to Cure Heart Disease

An administrative law judge upheld the Federal Trade Commission's ruling on POM's false advertising
Staff Writer

Photo Sasabune Omakase Modified: Flickr/erin/CC 4.0

Pomegranate may be a superfruit, but it probably isn't a cure-all for cancer. Unfortunately, POM Wonderful seemed to be implying that, and the Federal Trade Commission (FTC) was miffed.

Luckily for the FTC, an administrative law judge agreed that the brand was falsely advertising that their products would "treat, prevent, or reduce the risk of heart disease, prostate cancer, and erectile dysfunction," a press release noted.

The ruling bars POM Wonderful from making further health claims unless they have "substantial scientifice evidence." The FTC origianlly wanted POM to gain permission before advertising such benefits, again, but the judge felt that was overreaching. Still, you better hold off on chugging that POM juice until they come up with some paid-for, scientific research to shill their health benefits again.

Rate this Story